XDH and gout: The observation that combined oral administration of febuxostat—an inhibitor of xanthine oxidoreductase (XOR) used to treat gout and hyperuricemia—and inosine elevated both hypoxanthine and ATP levels in peripheral blood of healthy subjects [64], let Kamatani and colleagues hypothesize that PMD patients may potentially benefit from such treatment.